Return-Path: theeditor@technologynetworks.com
Received: from zimbra.bph.cxn (LHLO zimbra.chemaxon.com) (10.128.128.30) by
 zimbra.bph.cxn with LMTP; Wed, 24 Sep 2014 18:17:36 +0200 (CEST)
Received: from localhost (localhost.localdomain [127.0.0.1])
	by zimbra.chemaxon.com (Postfix) with ESMTP id 99C6A18B8202
	for <fcsiz@chemaxon.com>; Wed, 24 Sep 2014 18:17:36 +0200 (CEST)
X-Virus-Scanned: amavisd-new at zimbra.bph.cxn
X-Spam-Flag: NO
X-Spam-Score: 2.306
X-Spam-Level: **
X-Spam-Status: No, score=2.306 tagged_above=-10 required=6.6
	tests=[BAYES_00=-1.9, HTML_MESSAGE=0.001, LOTS_OF_MONEY=0.001,
	MIME_HTML_ONLY=0.723, RCVD_IN_DNSWL_BLOCKED=0.001,
	RCVD_IN_MSPIKE_H3=-0.01, RCVD_IN_MSPIKE_WL=-0.01, RDNS_NONE=3.5,
	SPF_PASS=-0.001, URIBL_BLOCKED=0.001] autolearn=no
Received: from zimbra.chemaxon.com ([127.0.0.1])
	by localhost (zimbra.bph.cxn [127.0.0.1]) (amavisd-new, port 10024)
	with ESMTP id 81ye1s8RAgyY; Wed, 24 Sep 2014 18:17:31 +0200 (CEST)
Received: from TNE.technet.local (unknown [209.160.53.185])
	by zimbra.chemaxon.com (Postfix) with ESMTP id D4B7918B81D3
	for <fcsiz@chemaxon.com>; Wed, 24 Sep 2014 18:17:30 +0200 (CEST)
Received: from TNE ([127.0.0.1]) by technet.local with MailEnable ESMTP; Wed, 24 Sep 2014 17:17:28 +0100
Reply-To: "ADME Tox News from Technology Networks" <theeditor@technologynetworks.com>
From: "ADME Tox News from Technology Networks" <theeditor@technologynetworks.com>
To: <fcsiz@chemaxon.com>
Subject: Animal Testing can Mislead Drug Discovery; HiTS Receives Funding; More
Date: Wed, 24 Sep 2014 17:17:26 +0100
Importance: Normal
X-Priority: 3 (Normal)
MIME-Version: 1.0
X-Mailer: Mach 5 Mailer version 4 RI{01444-a14ac}
Content-Type: text/html;
	charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable
Message-ID: <9690535BFADA44678D49EB8B2ABEC53C.MAI@technet.local>

<!DOCTYPE html PUBLIC '-//W3C//DTD XHTML 1.0 Transitional//EN' 'http://www.=
w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd'>
<html xmlns=3D'http://www.w3.org/1999/xhtml'>
<head>
<meta http-equiv=3D'Content-Type' content=3D'text/html; charset=3Dutf-8' />
<title>Technology Networks Newsletter</title></head>
<body style=3D'font-family: Arial, Helvetica, sans-serif; font-size: 12px;'>
<style type=3D'text/css'>
body,td,th {	font-family: Helvetica, sans-serif;	font-size: 12px;color: #33=
3;}a:link {color: #7c7c7c;}
a:visited {color: #7c7c7c;}span.preheader { display: none !important; }
</style>
<span class=3D'preheader' style=3D'display:none;'>Here is a selection of th=
e latest ADME Tox news from TechnologyNetworks.com...</span>
<table width=3D'720' cellspacing=3D'0' cellpadding=3D'10' style=3D'border:t=
hick #cdcdcd solid'>
<tr>
<td>
<table width=3D'700' cellspacing=3D'0' cellpadding=3D'0' style=3D'border:th=
in solid #cdcdcd'>
<tr>
<td colspan=3D'3' align=3D'left' valign=3D'top'>
<table width=3D'100%' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'>
<tr>
<td width=3D'84%' height=3D'67' align=3D'left' valign=3D'middle' bgcolor=3D=
'#cdcdcd' style=3D'padding-left:10px'>
<p>
<font face=3D'Helvetica, sans-serif' style=3D'font-size:36px;color:black'>
ADME Tox News
</font>
</p>
</td>
<td width=3D'16%' align=3D'right' valign=3D'top' bgcolor=3D'#cdcdcd'>
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://www.techn=
ologynetworks.com/admet'>
<img src=3D'http://images.technologynetworks.net/newsletterimages/admet/Hea=
derNew.jpg' alt=3D'ADME Tox' name=3D'' width=3D'200' height=3D'67' border=
=3D'0' align=3D'right' />
</a>
</td>
</tr>
<tr>
<td align=3D'left' valign=3D'middle' style=3D'padding-left:10px'>
<strong>Ferenc,</strong>
</td>
<td align=3D'right' valign=3D'top'>
<table width=3D'200' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'>
<tr>
<td width=3D'169' align=3D'right' style=3D'padding-top:5px'>
<p>
<a style=3D'color:#7c7c7c' href=3D'mailto:promotions@technologynetworks.com=
?subject=3DSend Advertising Rates for ADME Tox Newsletter'>
<strong>Promote Your Company</strong>
</a>
</p>
</td>
<td width=3D'31' align=3D'left' style=3D'padding-right:10px; padding-top:5p=
x; padding-left:3px'>
<a style=3D'color:#7c7c7c' href=3D'mailto:promotions@technologynetworks.com=
?subject=3DSend Advertising Rates for ADME Tox Newsletter'>
<img src=3D'http://images.technologynetworks.net/newsletterimages/admet/ADM=
ET_Small_Arrow.gif' alt=3D'' name=3D'' width=3D'21' height=3D'21' border=3D=
'0' align=3D'right'></a>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td colspan=3D'3' align=3D'left' valign=3D'top' style=3D'border-bottom:thin=
 solid #cdcdcd; padding-left:10px; padding-right:10px; padding-bottom:10px;=
 line-height:18px'>
<strong>
Here is a selection of the latest ADME Tox News...
</strong>
<br />
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/news.aspx?ID=3D170555'>Promise for Treatmen=
t of Pancreatic Cancer</a></strong><br/>
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/news.aspx?ID=3D170552'>LMTX&trade; in Clini=
cal Trials</a></strong><br/>
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/news.aspx?ID=3D170426'>HMS Receives $30 Mil=
lion for Therapeutic Science Program</a></strong><br/>
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/news.aspx?ID=3D170195'>Animal Testing can M=
islead Drug Discovery and Development</a></strong><br/>
</td>
</tr>
<tr>
<td colspan=3D'3' align=3D'center'>
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D160728&etype=3DTN&link=3Dhttp://www.absci=
ex.com/applications/biologics'>
<img src=3D'http://images.technologynetworks.net/newsletterimages/biologics=
_done_right_V2_700x200.jpg' border=3D'0' />
</a>
</td>
</tr>
<tr>
<td colspan=3D'3' style=3D'border-top: thin solid #cdcdcd'>&nbsp;

</td>
</tr>
<tr>
<td align=3D'center' valign=3D'top' style=3D'padding:7px; border-right:thin=
 solid #cdcdcd'>
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D166319&etype=3DTN&link=3Dhttp://www.proso=
lia.com/drug-imaging'><img src=3D'http://images.technologynetworks.net/news=
letterimages/massspec/prosolia_logo.jpg' border=3D'0' /></a>

</td>
<td width=3D'368' rowspan=3D"2" valign=3D'top' style=3D'padding:7px;'><tabl=
e width=3D'350' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'><tr><td wi=
dth=3D"350">
<p>
<font style=3D'font-size:14px'>
<strong>
Upcoming Events
</strong>
</font>
<br>
<br>
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/eventsid.aspx?ID=3D166901'>Clinical Trials =
Phase I and Phase IIA</a>
</strong><br/>
<strong>15 - 16 October 2014, Philadelphia, PA, USA</strong><br>
<br>
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/eventsid.aspx?ID=3D166922'>Evolution Summit=
</a>
  </strong><br/>
  <strong>20 - 22 October 2014, Monte-Carlo, Monaco</strong><br>
<br>
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/eventsid.aspx?ID=3D169128'>Pharmaceutical L=
abelling</a>
  </strong><br/>
  <strong>28 - 29 October 2014, Berlin, Germany</strong><br>
<br>
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/eventsid.aspx?ID=3D166714'>World Open Innov=
ation Forum 2014</a>
  </strong><br/>
  <strong>26 - 27 November 2014, Amsterdam, Netherlands</strong><br>
<br>
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/eventsid.aspx?ID=3D167385'>4th Drug Formula=
tion & Bioavailability</a>
  </strong><br/>
  <strong>26 - 28 January 2015, Boston, MA, USA</strong><br>
<br>
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/eventsid.aspx?ID=3D167464'>7th Annual Pre-F=
illed Syringes Conference and Exhibition</a>
  </strong><br/>
  <strong>28 - 29 January 2015, London, UK</strong></p></td></tr></table>
</td>
<td width=3D"166" rowspan=3D"2" valign=3D'top' style=3D'padding:7px; border=
-left:thin solid #cdcdcd'>
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D170670&etype=3DTN&link=3Dhttp://www.epost=
ers.net/'><img src=3D'http://images.technologynetworks.net/newsletterimages=
/eposters_miniad2.jpg' border=3D'0' /></a>

</td>
</tr>
<tr>
  <td valign=3D'top' style=3D'padding:7px; border-right:thin solid #cdcdcd;=
 line-height:17px'>Augment your WBA studies with <a style=3D"color:#015289"=
 href=3D"http://www.technologynetworks.com/admet/redirect.aspx?uid=3D129933=
6&cid=3D166319&etype=3DTN&link=3Dhttp://www.prosolia.com/products/desi-2d-s=
ource"><strong>DESI 2D and flowprobe&trade;</strong></a> mass spectrometry =
to get unambiguous detection of drugs, metabolites and biomarkers directly =
from animal tissue. <br>
    <br>
   =20
    <strong><a style=3D"color:#015289" href=3D"http://www.technologynetwork=
s.com/admet/redirect.aspx?uid=3D1299336&cid=3D166319&etype=3DTN&link=3Dhttp=
://www.prosolia.com/drug-imaging">Learn more &raquo; </a></strong><br>
    <br>
    <br></td>
</tr>
<tr>
<td colspan=3D'4'>
<table width=3D'100%' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'>
<tr>
<td colspan=3D'2' style=3D'border-bottom:thin solid #cdcdcd'>&nbsp;

</td>
</tr>
<tr>
<td colspan=3D'2'>&nbsp;

</td>
</tr>
<tr>
<td width=3D'350' valign=3D'top' style=3D'padding:7px; border-right:thin so=
lid #cdcdcd'>
<table width=3D'330'><tr><td style=3D'padding:7px;'>
<font style=3D'font-size:14px'>
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://www.techn=
ologynetworks.com/admet/productsid.aspx?ID=3D146793'>
<img src=3D'http://www.technologynetworks.com/MEDIA/images/companies/cyprot=
ex_logo.gif' alt=3D'' name=3D'' width=3D'150' height=3D'30' border=3D'0' al=
ign=3D'right'>
</a><strong>
Featured Products
</strong>
</font>
<br />
<strong>
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://www.techn=
ologynetworks.com/admet/productsid.aspx?ID=3D146793'>
High Content Toxicology: CellCiphr&reg; Premier
</a>
</strong>
</td>
</tr>
<tr>
<td align=3D'center' valign=3D'top' style=3D'padding:7px;'>
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://www.techn=
ologynetworks.com/admet/productsid.aspx?ID=3D146793'>
<img src=3D'http://www.technologynetworks.com/media/images/Products/Cyprote=
x-man.gif' alt=3D'' name=3D'' width=3D'230' height=3D'160' border=3D'0'>
</a></td></tr></table>
</td>
<td width=3D'350' align=3D'left' valign=3D'top' style=3D'padding:7px'><tabl=
e width=3D'330' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'><tr><td st=
yle=3D'padding:7px;'>
<font style=3D'font-size:14px'>
<strong>
Market Reports
</strong>
</font>
<br />
<a style=3D"color:#7c7c7c"href=3D"http://www.technologynetworks.com/admet/r=
edirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://marketrepo=
rts.com/hts-metrics-and-future-direction-trends-2014#.U9Ik6fk7t8F"><strong>=
HTS Metrics &amp; Future Direction Trends 2014</strong></a><br>
This market report summarizes the results of HTStec's global web-based benc=
hmarking survey on high throughput screening (HTS) metrics and future direc=
tions carried out in July 2014. The survey was initiated by HTStec as part =
of its tracking of life science marketplaces and to update our previous rep=
ort (April 2012). It followed an approach from Pharma to benchmark recent H=
TS metrics.</td></tr></table>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td colspan=3D'4'>
<table width=3D'100%' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'>
<tr>
<td colspan=3D'2' style=3D'border-bottom:thin solid #cdcdcd'>&nbsp;

</td>
</tr>
<tr>
<td colspan=3D'2'>&nbsp;

</td>
</tr>
<tr>
<td width=3D'350' valign=3D'top' style=3D'padding:7px; border-right:thin so=
lid #cdcdcd'>
<table width=3D'330' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'><tr><=
td colspan=3D'2' align=3D'left' style=3D'padding:7px'><font style=3D'font-s=
ize:14px'><strong>Webcasts</strong></font><br/>
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/webcastsid.aspx?ID=3D167702'>3D Organotypic=
 Liver Cultures and their Application in Predictive Toxicology</a></strong>
<br/>
Fozia Noor, Saarland University, speaking at Advances in Cellular Assays &a=
mp; Cell Culture 2014.</td></tr></table>
</td>
<td width=3D'350' align=3D'left' valign=3D'top' style=3D'padding:7px'><tabl=
e width=3D'330' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'><tr><td co=
lspan=3D'2' align=3D'left' style=3D'Padding: 7px;'><font style=3D'font-size=
:14px'><strong>Posters</strong></font><br />
<strong><a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.co=
m/admet/redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://w=
ww.technologynetworks.com/admet/postersid.aspx?ID=3D158456'>Pharmacokinetic=
 Delivery and Metabolizing Rate of Nicardipine Incorporated in Hydrophilic =
and Hydrophobic Cyclodextrins using Two-Compartment Model</a></strong>
<br/>
The dispersion routes of cyclodextrin complexes with nicardipine (NC), such=
 as hydrophilic hydroxypropyl-&szlig;-cyclodextrin (NC/HP&szlig;CD) and hyd=
rophobic triacetyl-&szlig;-cyclodextrin (NC/TA&szlig;CD), through the body =
for controlled drug delivery and sustained release have been examined.</td>=
</tr></table>
</td>
</tr>
<tr>
<td colspan=3D'2' align=3D'left' style=3D'border-bottom:medium solid #cdcdc=
d'>&nbsp;

</td>
</tr>
<tr>
<td colspan=3D'2' align=3D'left'>&nbsp;

</td>
</tr>
<tr>
<td width=3D'350' align=3D'left' valign=3D'top' style=3D'padding:7px; borde=
r-right:thin solid #cdcdcd'>
<table width=3D'330' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'><tr><=
td style=3D'padding:7px'>
<strong><span style=3D'font-size:14px'>Promote Your Company</span></strong>
<br />
<a style=3D'color:#7c7c7c' href=3D'mailto:promotions@technologynetworks.com=
?subject=3DSend Advertising Rates for ADME Tox Newsletter'>
<strong>Contact Us</strong></a>
 if you are interested in promoting your products or services to to those i=
nvolved in pre-clinical drug development.
</td></tr></table>
</td>
<td width=3D'350' align=3D'left' valign=3D'top' style=3D'padding:7px'>
<table width=3D'330' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'><tr><=
td style=3D'padding:7px'><em>
<strong>Volume 14, Issue 18</strong>
</em>
<br />
<strong>Your Username:</strong>
 fcsiz@chemaxon.com
<br/>
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://www.techn=
ologynetworks.com/admet/passwordreset.aspx'>
<strong>Password Reset</strong>
</a></td></tr></table>
</td>
</tr>
<tr>
<td colspan=3D'2' align=3D'left' style=3D'border-bottom:thin solid #cdcdcd'=
>&nbsp;

</td>
</tr>
<tr>
<td colspan=3D'2' align=3D'left'>
<table width=3D'100%' border=3D'0' cellspacing=3D'0' cellpadding=3D'0'>
<tr>
<td width=3D'47%' align=3D'center' valign=3D'top' >
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://www.techn=
ologynetworks.com'>
<img src=3D'http://images.technologynetworks.net/newsletterimages/GenomicsN=
ews/TechNet-CommunitiesnWhite.gif' alt=3D'' width=3D'300' height=3D'119' bo=
rder=3D'0' align=3D'top' />
</a>
<br />
Woodview  | Bull Lane | Sudbury | CO10 0FD | UK
<br />
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Subscr=
iptionManagement.aspx?uid=3D1299336&guid=3D{E5B93339-88D6-4300-82A9-BE55B94=
D793D}' target=3D'_blank'>Unsubscribe</a>
 |=20
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://www.techn=
ologynetworks.com/admet/privacy.aspx' target=3D'_blank'>
Privacy Policy and Disclaimer
</a>
</td>
<td width=3D'53%' align=3D'center' valign=3D'top' style=3D'padding:7px'>
<strong>
<font style=3D'font-size:14px'>
Click below to subscribe to other newsletters
</font>
<br />
</strong>
<font style=3D'font-size:10px'>
<span style=3D'padding:5px;'>
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_bl=
ank'>ADME Tox</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/agrige=
nomics/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}'> AgriG=
enomics Research</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/subscr=
ibe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}&amp;SiteID=3D48&amp;=
title=3DBiobanking' target=3D'_blank'>Biobanking</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/HTS/su=
bscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_blan=
k'>Biomolecular Screening</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Biolog=
ics/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D=
'_blank'>Biologics and Bioprocessing</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Proces=
sChem/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=
=3D'_blank'>Chemical Process Scale Up</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/cc/sub=
scribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_blank=
'>Cell Culture</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Chroma=
tography/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' targ=
et=3D'_blank'>Chromatography</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Crysta=
llography/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' tar=
get=3D'_blank'>Crystallography</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Enviro=
nmental/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' targe=
t=3D'_blank'>Environmental Analysis</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/subscr=
ibe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}&amp;SiteID=3D32&amp;=
title=3DePosters' target=3D'_blank'>ePosters</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/subscr=
ibe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}&amp;SiteID=3D62&amp;=
title=3DFlow Chemistry' target=3D'_blank'>Flow Chemistry</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/FAB/su=
bscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_blan=
k'>Food & Beverage Analysis</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/FS/sub=
scribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_blank=
'>Forensic Science</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/RNAi/s=
ubscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_bla=
nk'>Gene Silencing</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Genomi=
cs/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'=
_blank'>Genomics Research</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Genoty=
ping/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=
=3D'_blank'>Genotyping &amp; Gene Expression</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Immuno=
logy/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=
=3D'_blank'>Immunology</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Inform=
atics/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}'> Inform=
atics</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/LOAC/s=
ubscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_bla=
nk'>Lab-on-a-Chip</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/subscr=
ibe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}&amp;SiteID=3D39&amp;=
title=3DLabTube' target=3D'_blank'>LabTube.tv</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/LIMS/s=
ubscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_bla=
nk'>LIMS &amp; ELNS</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/MassSp=
ec/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'=
_blank'>Mass Spectrometry</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/MedChe=
m/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_=
blank'>Medicinal Chemistry</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Metabo=
lomics/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=
=3D'_blank'>Metabolomics &amp; Lipidomics</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Diagno=
stics/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=
=3D'_blank'>Molecular &amp; Clinical Diagnostics</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Nano/s=
ubscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_bla=
nk'>NanoBiotech &amp; NanoMedicine</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/ngs/su=
bscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D'_blan=
k'>Next Gen Sequencing</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Pharma=
Outsourcing/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' t=
arget=3D'_blank'>Pharma Outsourcing</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Proteo=
mics/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=
=3D'_blank'>Proteomics</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/qPCR/s=
ubscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}'>qPCR</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/Spectr=
oscopy/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=
=3D'_blank'>Spectroscopy</a> |=20

<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/StemCe=
lls/subscribe.aspx?GUID=3D{E5B93339-88D6-4300-82A9-BE55B94D793D}' target=3D=
'_blank'>Stem Cell Research</a>

</span>
</font>
</td>
</tr></table>
</td>
</tr>
<tr>
<td colspan=3D'2' align=3D'left'>
</td>
</tr>
<tr>
<td colspan=3D'2' align=3D'left' valign=3D'top'>
<a style=3D'color:#7c7c7c' href=3D'http://www.technologynetworks.com/admet/=
redirect.aspx?uid=3D1299336&cid=3D154842&etype=3DTN&link=3Dhttp://www.twitt=
er.com/Tech_Networks'>
<img src=3D'http://images.technologynetworks.net/newsletterimages/admet/Foo=
terNew.jpg' alt=3D'' width=3D'700' height=3D'48' border=3D'0' usemap=3D'#Ma=
p' />
</a>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<IMG height=3D1 src=3D'http://www.technologynetworks.com/redirect.aspx?uid=
=3D1299336&cid=3D154841&etype=3DTNO&link=3Dhttp://www.technologynetworks.co=
m/admet' width=3D'1'>
<map name=3D'Map'><area shape=3D'rect' coords=3D'6,2,242,46' href=3D'http:/=
/www.technologynetworks.com/admet/redirect.aspx?uid=3D1299336&cid=3D154842&=
etype=3DTN&link=3Dhttp://www.twitter.com/Tech_Networks' target=3D'_blank' a=
lt=3D'Twitter'></map><style>@media print{ #_t { background-image: url('http=
s://74e0e1z1.emltrk.com/74e0e1z1?p&d=3D1299336');}} div.OutlookMessageHeade=
r {background-image:url('https://74e0e1z1.emltrk.com/74e0e1z1?f&d=3D1299336=
')} table.moz-email-headers-table {background-image:url('https://74e0e1z1.e=
mltrk.com/74e0e1z1?f&d=3D1299336')} blockquote #_t {background-image:url('h=
ttps://74e0e1z1.emltrk.com/74e0e1z1?f&d=3D1299336')} #MailContainerBody #_t=
 {background-image:url('https://74e0e1z1.emltrk.com/74e0e1z1?f&d=3D1299336'=
)}</style><div id=3D"_t"></div>
<img src=3D"https://74e0e1z1.emltrk.com/74e0e1z1?d=3D1299336" width=3D"1" h=
eight=3D"1" border=3D"0" /></body>
</html>